1-800-710-4674

Blogs

  • OHC Studies Drug That May Become a New First-Line Treatment for Lung Cancer

    Cynthia Chua, MD, OHC Medical Oncologist and Hematologist, Blogs 0 comments
    April 18, 2019

    lung cancer clinical trials

    When a patient hears the word cancer, they want to know they have access to the latest treatments available to fight their cancer. When you choose OHC doctors, you have access to their nationally recognized clinical trials and the most promising treatment. The program provides patients with access to new, innovative treatments that are not […]

    Read More
  • Palliative Care vs. Hospice Care: OHC Invites You to Learn the Difference and Know the Benefits

    Paula Weisenberger, MD, Medical Oncologist and Hematology at OHC, Blogs 0 comments
    April 5, 2019

    palliative care vs hospice care

    At OHC, we understand that when someone is diagnosed with cancer, their lives are forever changed. It can affect every aspect of their physical and emotional well-being. At OHC, not only are we the region’s leaders at treating cancer, we also provide support services that surround our patients with everything they need throughout their journey. […]

    Read More
  • OHC Helps Patients Attack Their Esophageal Cancer While Providing Comfort and Symptom Relief

    Marc R. Mosbacher, MD, a radiation oncologist at OHC, Blogs 0 comments
    April 1, 2019

    esophageal cancer screenings

    If you’ve received a diagnosis of esophageal cancer, you want treatment from cancer experts who treat you like a person and not a diagnosis. OHC understands the complications associated with this disease and treatment can be extremely challenging. That’s why we not only attack your cancer, but we also offer support to help with the […]

    Read More
  • Recognizing OHC’s Doctors for Their Unwavering Spirit

    A tribute to the doctors and providers at OHC on National Doctors’ Day, Blogs 0 comments
    March 29, 2019

    National Doctors Day Dr. Waterhouse

    Nothing is more rewarding to a cancer patient than hearing their disease is either in remission or is no longer detectable.  At OHC, our doctors routinely attack cancer with the newest approaches and treatments while constantly searching for the best solution to beat cancer so more patients can actually hear those words. National Doctor’s Day […]

    Read More
  • OHC Contributes to a Reduction in Cancer Death Rates

    Basel Yanes, MD, Medical Oncologist and Hematologist at OHC, Blogs 0 comments
    March 28, 2019

    cancer death rates decline

    Every day the doctors at OHC are attacking cancer with leading edge approaches and the newest treatments while constantly searching for the best solution to beat cancer. This is how OHC has been able to contribute, first-hand, to a decline in cancer death rates – by providing education regarding improvements in early detection, offering advanced […]

    Read More
  • How to Know if Your Colorectal Cancer is Hereditary

    Andy Guinigundo, MSN, APRN, Advanced Practice Provider and Cancer Genetic Specialist at OHC, Blogs 0 comments
    March 27, 2019

    hereditary colorectal cancer

    Receiving a diagnosis of colorectal cancer is life altering and can be scary. But, knowledge is empowering. That’s why OHC provides education to help patients stay focused on their number one job of getting well. In recognition of colorectal cancer month, OHC is highlighting education on the role your heredity can play in predisposing you […]

    Read More
  • OHC Strengthens the Attack Against Multiple Myeloma

    Miguel Islas-Ohlmayer, MD, Medical Oncologist, Hematologist, and Transplant Specialist at OHC, Blogs 2 comments
    March 20, 2019

    At OHC, our blood and marrow transplant specialists are bringing significant advancements for the treatment of multiple myeloma. With the approval of new drugs that target the disease much more precisely, OHC offers these drugs for patients whose multiple myeloma has returned or hasn’t responded to other treatments. Daratumumab (Darzalex) and Elotuzumab (Empliciti) are two […]

    Read More